Long-term results of tricuspid valve replacement and the problem of prosthetic valve thrombosis

Thorburn, Charles W.; Morgan, John J. B.; Shanahan, Mark X.; Chang, Victor P.

doi:10.1016/0002-9149(83)90357-0

Cited by 155 publications

(58 citation statements)

References 16 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The overall 5, 10, and 15 year survival rates in this series are similar to rates in other studies. Five year survival rates were reported to range from 42% to 67%,'7 1921 23 10 year rates from 37% to 55%,2 23 An important finding of this review was the significant incidence of bradyarrhythmias requiring permanent pacemaker implantation. The causes are multifactorial, including intraoperative damage to the conduction system, fibrosis secondary to chronic compressive effects of the rigid mitral and tricuspid sewing ring, and rheumatic heart disease.…”

Section: Discussionmentioning

confidence: 85%

Results of triple valve replacement in 91 patients: perioperative mortality and long-term follow-up.

Gersh

Schaff²,

Vatterott

et al. 1985

Circulation

View full text Add to dashboard Cite

Between 1961 and 1984, 91 patients underwent simultaneous triple valve replacement at the Mayo Clinic. Of the 273 prosthetic valves used, 77% were Starr-Edwards. Perioperative (30 day) mortality was 24% to 27% between 1962 and 1974 and 7% between 1975 and 1983 (p = .17 1, 130-137, 1985. OVER the past 10 years, reports from many centers have defined the early and late results of cardiac valve replacement for most categories of patients.'-9 The outcome of triple valve replacement (aortic, mitral, and tricuspid valve replacement) is less well defined, primarily because of the relatively small numbers of patients who have undergone the operation. With the trend toward conservative tricuspid valve surgery coupled with the development of more predictable methods of valve repair and the declining incidence of rheumatic heart disease in the United States, triple valve replacement is less frequently required than it was previously. Nonetheless, rheumatic heart disease with involvement of multiple valves remains a serious problem in many countries.'0 Accordingly, we report our experience in 91 consecutive patients with rheumatic heart disease who underwent simultaneous triple valve From the Mayo Clinic and Mayo Foundation, Rochester, MN.

show abstract

Section: Discussionmentioning

confidence: 85%

Results of triple valve replacement in 91 patients: perioperative mortality and long-term follow-up.

Gersh

Schaff²,

Vatterott

et al. 1985

Circulation

View full text Add to dashboard Cite

show abstract

“…Obstruction of tricuspid mechanical prosthesis is 20 times more frequent than left-sided PVT. 4 Similarly, mitral PVT is 2-3 times more frequent than thrombosis of an aortic prosthesis. Interruption of oral anticoagulant treatment for anticipated non cardiac surgery and pregnancy represent high risk situations for patients with prosthetic valves.…”

Section: Discussionmentioning

confidence: 99%

Prosthetic valve thrombosis in a tertiary cardiac centre

et al. 2017

View full text Add to dashboard Cite

Background and Aims: Prosthetic valve thrombosis remains a major complication of valve replacement surgeries in Nepal. A number of patients present with thrombotic complications mainly due to poor anticoagulation status with irregular INR checkup at the remote areas of Nepal. Thrombolysis is the preferred method in the management of stuck valve patients due to financial issues . We aimed to retrospectively study the clinical profile and management trends of stuck prosthetic valveMethods: A one year retrospective data of 23 patients (Jan 2015 - Jan 2016) admitted with diagnosis of prosthetic valve thrombosis were studied. The demographic profile, clinical parameters and in hospital outcome were analysed.Results: Out of 23 patients, majority were female (52.2%) with the age group 13-49 years (mean = 35). Sixteen patients (69.6%) presented with INR value < 1.5 at admission. Twenty patients ( 86.9%) were thrombolysed with streptokinase while 3 patients ( 13.1 %) were subjected to treatment with tenecteplase . Valve thrombosis was most common at the mitral position 17 (73.9%) patients. In hospital mortality was seen in 5 ( 21.7%) patients and there were no major bleeding events or new stroke noted.Conclusion: Majority of patients with prosthetic valve thrombosis presented with a subtherapeutic INR value. Thrombolysis can be a useful option in the management of prosthetic valve thrombosis patients in a less resourceful country.Nepalese Heart Journal 2017; 14(1): 9-11

show abstract

“…43 However, the advent of somatostatin analogs and other antitumor therapies may theoretically protect the valve from deposition of further carcinoid plaques. Tissue valves have the advantage of not requiring anticoagulation and consequently lower the risk of bleeding in patients with hepatic dysfunction, reduce the risk of valve thrombosis (mechanical valve thrombosis is 4% per year 44 ), and allow further procedures such as hepatic dearterialization to proceed at a later date. Therefore, choice of prosthesis should be tailored to individual patient risk of bleeding, life expectancy, and future interventions.…”

Section: Surgicalmentioning

confidence: 99%